Implantable cardioverter defibrillators--for whom?

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

Journal of internal medicine·2017

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial.

Journal of thrombosis and haemostasis : JTH·2015

Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.

International journal of cardiology·2013

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.

International journal of clinical practice·2013

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.

Journal of thrombosis and haemostasis : JTH·2011

Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry.

Journal of cardiovascular electrophysiology·2010

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Review of ultrasonic methods for monitoring, damage detection, and processing of lithium-ion batteries throughout their life cycle.

The Journal of the Acoustical Society of America·2026

Neural correlates of performance and mental workload dynamics during learning of upper-limb body-powered and myoelectric prostheses.

Journal of neural engineering·2026

Optimal Control Drives Ultrafast and Energy-Efficient Magnetization Switching in Van der Waals Magnets.

Advanced materials (Deerfield Beach, Fla.)·2026

Polytetrafluoroethylene and Aluminum Powder as an Alternative to Copper in Car Brake Composite Friction Materials-Part 2, Simulation Studies of Braking Process.

Materials (Basel, Switzerland)·2026

Determining the Impedance of an Eddy Current Probe Placed over a Defect-Free Conductive Cylinder with a Centred Circular Hole.

Materials (Basel, Switzerland)·2026

Research on Thermal Runaway Monitoring Methods for Lithium-Ion Batteries Based on Continuous Acoustic Emission Technology.

Sensors (Basel, Switzerland)·2026

Related Experiment Videos

Implantable cardioverter defibrillators--for whom?

Related Concept Videos

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial.

Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.

Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Review of ultrasonic methods for monitoring, damage detection, and processing of lithium-ion batteries throughout their life cycle.

Neural correlates of performance and mental workload dynamics during learning of upper-limb body-powered and myoelectric prostheses.

Optimal Control Drives Ultrafast and Energy-Efficient Magnetization Switching in Van der Waals Magnets.

Polytetrafluoroethylene and Aluminum Powder as an Alternative to Copper in Car Brake Composite Friction Materials-Part 2, Simulation Studies of Braking Process.

Determining the Impedance of an Eddy Current Probe Placed over a Defect-Free Conductive Cylinder with a Centred Circular Hole.

Research on Thermal Runaway Monitoring Methods for Lithium-Ion Batteries Based on Continuous Acoustic Emission Technology.

Related Experiment Videos

Implantable cardioverter defibrillators--for whom?

Related Concept Videos

Related Articles